Past CureTalks
Evolving Treatment Landscape of Psoriasis. More than Skin Deep.
Psoriasis is one of the most common skin ailments, affecting about 2 percent of the population, across gender, age or socioeconomic status. The impact of this autoimmune skin condition goes much deeper with raised cardiovascular risk, inflammatory arthritis and other…
Fighting Polycystic Ovary Syndrome (PCOS) – New Developments in Symptoms Management & Treatment
PCOS is a little understood life changing syndrome. What we know about PCOS are the disturbing symptoms it creates in our bodies, but we only know the tip of the iceberg when it comes to reasons behind why these symptoms…
New Developments in Breast Cancer Screening and Treatment
Breast cancer is the second most common cancer in women (although men can get it too). Some breast cancers are driven by inherited mutations while most are sporadic, driven by unknown causes or by environmental or behavioral factors like obesity,…
Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management
Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although the exact nature and biological properties of these cells remain elusive, multiple myeloma stem cells (MMSCs) have…
Understanding the FDA approved New Drug, Selinexor and its Use in Multiple Myeloma
Recently, the FDA approved a new cancer drug called Selinexor. This drug has been found to be successful in treating multiple myeloma in patients who have exhausted all other existing treatment options. Selinexor works on a different mechanism compared to…